Clinical Trials
37 trialsTherapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Medical College of Wisconsin
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
Fred Hutchinson Cancer Center
Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems
Universitair Ziekenhuis Brussel
VENAZA-5S
University of Leipzig
Autologous Testicular Tissue Transplantation
Universitair Ziekenhuis Brussel
COMPLHEMATO
University Hospital, Limoges
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Medical College of Wisconsin
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
University of Southern California
CHIS
Assistance Publique - Hôpitaux de Paris
MDS
Thomas Jefferson University
HORIZONS
Massachusetts General Hospital
Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
Memorial Sloan Kettering Cancer Center
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Medical College of Wisconsin
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
University of Michigan Rogel Cancer Center
CTL-DP 01
Nantes University Hospital
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
ReSTORE
Herlev and Gentofte Hospital
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
M.D. Anderson Cancer Center
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
M.D. Anderson Cancer Center
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Stanford University
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant
Fred Hutchinson Cancer Center
JACKPOT22
The First Affiliated Hospital of Guangzhou Medical University
Bone Marrow Grafting for Leukemia and Lymphoma
Stanford University
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
Zhejiang University
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Rigshospitalet, Denmark
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
University of Colorado, Denver
PAIA-Haplo
Fujian Medical University
BMT-CARE
Massachusetts General Hospital
APACCHE
Centre Hospitalier Universitaire de la Réunion
Multiple Myeloma Prognostic Indices
Assiut University
HEME Home Transfusion Program
Dana-Farber Cancer Institute
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
Zhejiang University
Muscle Dysfunction in Patients With Haematological Diseases
Rigshospitalet, Denmark
EHPVO-HEM
Assiut University